Labcorp Holdings (LH) EBT (2009 - 2026)

Labcorp Holdings has reported EBT for 18 years, with the latest figure at $319.7 million in Q1 2026.

• Quarterly EBT rose 16.17% year-over-year to $319.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (up 22.91% YoY) and the FY2025 annual result came in at $1.1 billion, up 15.42% from the prior year.
• EBT improved to $319.7 million in Q1 2026 per LH's latest filing, from $190.6 million in the prior quarter.
• Over five years, EBT peaked at $640.1 million in Q1 2022 and troughed at -$147.1 million in Q4 2023.
• A 5-year average of $251.9 million and a median of $272.3 million in 2023 frame the typical range for EBT.
• The sharpest annual moves came in 2023 and 2024: EBT slumped 1542.16% in 2023, then surged 224.95% in 2024.
• Over 5 years, EBT stood at $10.2 million in 2022, then plunged by 1542.16% to -$147.1 million in 2023, then soared by 224.95% to $183.8 million in 2024, then advanced by 3.7% to $190.6 million in 2025, then jumped by 67.73% to $319.7 million in 2026.
• According to Business Quant data, EBT over the past three periods registered $319.7 million, $190.6 million, and $337.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.